GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

IX Biopharma 42C.SI · SGD

Health Care · SGX · 🇸🇬 Singapore

Compare

0.45

-4.26%

Close of 6 Nov 2026, in SGD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Forecasts

Analyst averages for the fiscal years ahead

FY2027FY2028FY2029
RevenueSGD 17.8mSGD 54.2mSGD 194.8m
Revenue, highestSGD 20.6mSGD 54.9mSGD 198.9m
Revenue, lowestSGD 14.9mSGD 53.5mSGD 190.8m
Earnings per share-0.010.000.13
Earnings per share, highest-0.010.000.13
Earnings per share, lowest-0.01-0.000.12
Analysts221

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

3 / 10

Revenue growth 1.7% a year over 10 years. Return on equity -51.9%.

Model fair value

0.33

From earnings —, from revenue 0.33.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.